You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上实城市开发(00563.HK)附属向关连方提供项目管理服务 涉管理费2,000万人币
阿思达克 11-20 09:33
上实城市开发(00563.HK)公布关连交易,公司之全资附属上实城开上海建设与上海上药生物医药订立项目管理服务协议,上实城开上海建设同意就项目向对方提供项目管理服务,管理费总额为2,000万元人民币。

上海上药生物医药为项目之开发商,项目位於上海市浦东新区张江路92号,总建筑面积约为12.6万平方米。

上海上药生物医药为上海医药集团之全资附属,而上海医药集团则为上海上实之非全资附属。公司控股股东上实集团为对上海上实行使国有股东权利之获授权代表。因此,上海上药生物医药为上实集团之联系人及公司之关连人士。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account